This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

proofread

Team uses 'nanoruler' to determine threshold for tissue permeability of brain tumors

What is the optimal size that is more likely to accumulate in brain tumors selectively?
A schematic illustration of size-tunable PEG-grafted copolymers (gPEGs) for optimizing the passive glioblastoma multiforme (GBM)targeting. MW, molecular weight; BBTB, blood−brain tumor barrier; i.v., intravenous; RES, reticuloendothelial system. Credit: Kanjiro Miyata's Lab

Currently, there is no effective treatment for glioblastoma multiforme (GBM), the most frequent and malignant type of brain tumor. Some low molecular weight antitumor agents are used to permeate the gaps between endothelial cells in the BBTB (blood−brain tumor barrier), which is a characteristic blood vessel structure and formed by the partial collapse of the blood−brain barrier, but they are rapidly excreted from the kidneys, resulting in low GBM accumulation.

Additionally, their nonspecific distribution in healthy tissues often induces severe side effects such as myelosuppression and immunosuppression. It is known that 30−100 nm-sized nanomedicines avoid rapid renal excretion and increase drug accumulation efficiency in some tumor models. However, the GBM accumulation level of such nanomedicines remains limited, presumably because of the relatively low blood vessel permeability in the BBTB.

Now, the Innovation Center of NanoMedicine (iCONM) has announced with the Graduate School of Engineering of The University of Tokyo that a group led by Prof. Kanjiro Miyata, Visiting Scientist of iCONM (Professor, Department of Materials Engineering, The University of Tokyo), has found that the threshold for tissue permeability of brain tumors is in the range of 10−30 nm, using a nanoruler, which is a biocompatible polymer used for measurement of gaps in the body.

In particular, when the size of the nanoruler is adjusted to 10 nm, it achieves an unprecedentedly high brain tumor accumulation. Obtained results have provided significant guidance for the design of future brain tumor .

Miyata and the team studied size-dependent GBM targetability using a size-tunable stealth polymer, termed a "polymeric nanoruler," and reported the results in the journal Bioconjugate Chemistry.

Small gPEGs exhibited efficient brain tumor accumulation, with 10 nm of gPEGs achieving the highest accumulation level (19 times higher than that in the normal brain region and 4.2 times higher than that of 30 nm of gPEGs), presumably because of the optimal size associated with enhanced BBTB permeability and prolonged blood circulation.

In conclusion, this study explored the size effect of nanomedicine on passive GBM targeting with size-tunable poly()-grafted copolymers (gPEGs) as polymeric nanorulers (ranging from 8.5 to 30 nm).

Miyata will report on the drug conjugation and optimization for the enhanced GBM-targeted drug delivery in future work. Overall, this study provides a useful molecular design to develop GBM-targeted nanomedicines for chemotherapy, , photodynamic/thermal therapy, and diagnostics.

More information: Yukine Ishibashi et al, Size-Dependent Glioblastoma Targeting by Polymeric Nanoruler with Prolonged Blood Circulation, Bioconjugate Chemistry (2024). DOI: 10.1021/acs.bioconjchem.4c00235

Journal information: Bioconjugate Chemistry

Provided by Innovation Center of NanoMedicine

Citation: Team uses 'nanoruler' to determine threshold for tissue permeability of brain tumors (2024, July 8) retrieved 22 July 2024 from https://phys.org/news/2024-07-team-nanoruler-threshold-tissue-permeability.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Breakthroughs in nanosized contrast agents and drug carriers through self-folding molecules

56 shares

Feedback to editors